The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Mast Cell Survival and Activation by IgE in the Absence of Antigen: A Consideration of the Biologic Mechanisms and Relevance
Abstract
Mast cells are not only major effector cells in allergy and host defense against parasites and bacteria but also important cellular components in other immune responses. Recent studies on the effects of monomeric IgE on mast cell survival and activation have made an impact on our view of the IgE binding to its high-affinity receptors, FcεRI. Traditionally, IgE binding to FcεRI has been considered as a passive action of “sensitization” before receptor aggregation by Ag. However, recent studies indicate that at high concentrations some monoclonal IgEs have effects on mast cells similar to or identical to those induced by IgE+Ag stimulation. These effects may be due to induction of FcεRI aggregation by these IgEs in the absence of Ag. This review will synthesize recent findings of the heterogeneity of IgEs in their ability to induce survival and activation events, their mechanisms, the potential in vivo significance of IgE-FcεRI interactions, and the implications of the mouse studies to human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When mast cell- or basophil-bound IgE antibodies recognize antigens that are at least bivalent, rapid aggregation of the FcεRI initiates complex intra-cellular signaling pathways. This ultimately results in the release, by such activated effector cells, of a wide variety of mediators with diverse biological effects [5, 6, 8–11].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“Beyond this traditional understanding, our knowledge of mast cell functions has recently been substantially expanded (6, 7) and now includes those in autoimmunity such as experimental allergic encephalomyelopathy and rheumatoid arthritis (8, 9), delayed-type hypersensitivity (10), angiogenesis (11), and congestive hea…”
BackgroundCoker, H. A., Durham, S. R., & Gould, H. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5602 · Cited by 149
Research works printed but not linked: 86
- 1999, Curr. Opin. Immunol., 53
- 1996, Nature, 77
- 1996, Nature, 75
- 1990, J. Immunol., 259
- 1998, Nature, 90
- 2001, J. Exp. Med., F1
- 2005, Nat. Immunol., 135
- 2000, J. Exp. Med., 813
- 2002, Science, 1689
- 2000, J. Exp. Med., 1441
- 1999, Genes Dev., 1382
- 2002, J. Exp. Med., 375
- 1999, Annu. Rev. Immunol., 931
- 2002, Nat. Immunol., 741
- 1999, Nature, B24
- 2002, Nat. Rev. Immunol., 773
- 2000, Curr. Opin. Immunol., 624
- 1985, Proc. Natl. Acad. Sci. USA, 1522
- 1996, Immunol. Lett., 129
- 1997, J. Exp. Med., 663
- 2001, Immunity, 791
- 2001, Immunity, 801
- 2002, J. Exp. Med., 229
- 2003, Proc. Natl. Acad. Sci. USA, 12911
- 2003, J. Invest. Dermatol., 1425
- 2004, Am. J. Physiol., C256
- 2004, J. Immunol., 4048
- 2003, Blood, 1405
- 2005, Blood, 3222
- 1986, Eur. J. Immunol., 689
- 1993, Immunol. Today, 222
- 1990, Cell, 203
- 1995, Cell, 213
- 2005, J. Immunol., 4461
- 1980, J. Immunol., 2728
- 1980, J. Immunol., 775
- 2003, Science, 1362
- 2003, Nat. Immunol., 849
- 2004, J. Biol. Chem., 12312
- 1989, J. Exp. Med., 233
- 1995, Proc. Natl. Acad. Sci. USA, 9201
- 1997, J. Biol. Chem., 4276
- 2004, J. Immunol., 2374
- 2004, J. Immunol., 4317
- 2001, J. Immunol., 1290
- 2001, J. Immunol., 3427
- 1994, Am. J. Pathol., 321
- 2004, J. Immunol., 1139
- 2003, Science, 1859
- 2004, Blood, 3093
- 2005, Blood, 2059
- 1991, J. Clin. Invest., 446
- 2002, Immunity, 441
- 2004, J. Exp. Med., 959
- 2003, Curr. Opin. Immunol., 639
- 2005, J. Immunol., 4495
- 2005, Eur. J. Immunol., 460
- 2005, Cell Death Differ., 136
- 2003, Blood, 1290
- 1999, J. Immunol., 6162
- 2000, J. Immunol., 6262
- 2001, J. Exp. Med., 1561
- 1994, Nature, 367
- 1999, Int. Immunol., 987
- 1997, Int. Immunol., 461
- 1997, Parasitology, S33
- 1998, J. Allergy Clin. Immunol., 330
- 2003, J. Immunol., 5602
- 1997, Eur. J. Immunol., 2899
- 2001, Eur. J. Immunol., 3422
- 1999, Immunology, 646
- 2001, J. Allergy Clin. Immunol., 686
- 1995, Allergy, 851
- 2003, Int. Immunopharmacol., 909
- 2003, Nat. Immunol., 965
- 2003, Nat. Immunol., 974
- 2003, Nat. Immunol., 982
- 2002, Blood, 3861
- 2004, Immunity, 381
- 1997, Lab. Invest., 185
- 1999, J. Immunol., 5455
- 2003, Life Sci., 2571
- 1987, J. Immunol., 506
- 1996, J. Exp. Med., 1265
- 2003, Annu. Rev. Immunol., 579
- 1989, Nature, 64
Cited by
Sorted by citations
Metcalfe, D. D. (2008) · Blood · doi:10.1182/blood-2007-11-078097 · Cited by 536
Mast cells and IgE in defense against venoms: Possible “good side” of allergy?
Galli, S. J., Starkl, P., Marichal, T., & Tsai, M. (2016) · Allergology International · doi:10.1016/j.alit.2015.09.002 · Cited by 73
Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy
Galli, S. J., Metz, M., Starkl, P., Marichal, T., & Tsai, M. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00118-6 · Cited by 57
Metadata
- Authors
- Kawakami, T., & Kitaura, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-01
- Volume
- 175
- Issue
- 7
- Pages
- 4167-4173
- ISSN
- 0022-1767
- 1550-6606
- Cited by
- 120
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review